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1. Introduction 
The glutamine synthetase (L-glutamate:ammonia 
ligase (ADP) EC 6.3.1.2) activity of many mammalian 
cells in culture decreases with increasing glutamine 
concentrations in the medium [l-4]. Radioimmuno- 
precipitation experiments with hepatoma tissue cul- 
ture (HTC) cells have shown that glutamine decreases 
glutamine synthetase activity by specifically accelerat- 
ing the degradation of the enzyme [5]. Although a 
considerable amount of information has been obtained 
about the properties of the glutamine synthetase deg- 
radation system [4-81, details of the pathway of deg- 
radation of the enzyme are still unknown, An obstacle 
to the elucidation of this pathway has been the failure 
to obtain glutamine-modulated breakdown of gluta- 
mine-synthetase in cell-free systems (unpublished). 
An alternative approach is to introduce labeled enzyme 
into unlabeled cells by an injection procedure and to 
study its degradation in vivo. Here, we have micro- 
injected ‘251-labeled rat liver glutamine synthetase into 
HTC cells by erythrocyte ghost-mediated injection [9], 
and could demonstrate that glutamine specifically 
accelerates its degradation. Pepstatin, a peptide prot- 
tease inhibitor impermeable to the cells, was coinjected 
with 12’1-glutamine synthetase and its effects on the 
degradation of the enzyme were investigated. 
2. Materials and methods 
2 .l . Cells and media 
Growth of HTC cells, clone GM22 and media were 
as in [6]. Tricine-buffered saline contained 160 mM 
NaCl and 20 mM Tricine-NaOH (pH 7.4). 
Elsevier/North-Holland Biomedical Press 
2.2. Iodination of proteins 
Glutamine synthetase purified as in [lo] was iodi- 
nated according to [ 111. The reaction time was 5 s 
at 0-4°C. Free “‘1 was removed by centrifugation 
through Sephadex G-25 [ 121. The preparations con- 
tained l-2% of trichloroacetic acid-soluble 12’I. 
Bovine serum albumin (BSA) was iodinated by the 
same procedure. 
2.3. Loading of human erythrocyte ghosts 
Erythrocyte ghosts were loaded as in [9]. Briefly, 
1251-labeled proteins (0.5 mg/ml) and cytochrome c 
(0.5 mg/ml) were added to 30% (v/v) washed erythro- 
cytes in 160 mM NaCl and 20 mM Tricine-NaOH 
(pH 7.4). The mixture was dialyzed against 500 vol. 
40 mM KC1 plus 10 mM Tricine-NaOH (pH 7.4) at 
4°C for 90 min. The ghosts were resealed and washed 
3 times with Tricine-buffered saline. The washed ghost 
suspension was found to be virtually free of unbound 
12’1 (<0.3% of the total counts). 
2.4. Fusion of loaded ghosts with HTC cells 
The procedure was essentially as in [9]. The fusion 
system contained 1 X lo7 loaded erythrocyte ghosts/ 
ml, 2 X lo6 HTC cells/ml, 0.2 mM La2(N03)3, and 
400 hemagglutinating units/ml of Sendai virus in Tri- 
tine-buffered saline. 
2.5 . Release of trichloroacetic acid-soluble radioactivity 
from cells 
HTC cells which had been fused with loaded eryth- 
rocyte ghosts (5 X 10’ cells/ml) were incubated with 
the appropriate additions at 37°C with gentle shaking. 
At intervals 1 ml samples were removed, the cells were 
sedimented, and trichloroacetic acid was added to the 
63 
Volume 128. number 1 FEBS LETTERS June 1981 
supernatant to a final concentration of 10% (w/v). 
The trichloroacetic acid-souble counts in the medium 
were determined in a gamma counter. The cells were 
washed with phosphate-buffered saline and incubated 
with 0.83% NH4Cl at 37°C for 15 min to lyse adsorbed 
ghosts, washed with phosphate-buffered saline and 
treated with 10% (w/v) trichloroacetic acid. Radioac- 
tivity in the pellets gave the trichloroacetic acid-insol- 
uble counts in cells. Results are expressed as percent 
of injected counts in trichloroacetic acid-soluble 
material [(trichloroacetic acid-soluble counts in medi- 
um/trichloroacetic acid-insoluble counts in cells at 
zero time) X 1001. 
2.6. SDS-polyacrylamide gel electrophoresis 
Cells were sedimented, washed and treated with 
0.83% NH4C1 as described. Cell pellets containing 
-2 X 10’ cells, were examined by electrophoresis on 
a 10% SDS -polyacrylamide slab gel followed by 
autoradiography [ 131. 
2.7. Materials 
Pepstatin [ 141 was the generous gift of Dr H. 
Umezawa, Microbial Chemistry Research Foundation, 
Tokyo. Na12’I was purchased from the Radiochemical 
Centre, Amersham. Cycloheximide, L-methionine sul- 
fone, L-glutamine and BSA were obtained from Sigma. 
3. Results 
Glutamine synthetase from rat liver labeled with 
“‘1 was trapped in human erythrocyte ghosts and the 
ghosts contents were injected into HTC cells using 
Sendai virus-mediated fusion [9]. The degradation of 
the labeled enzyme was followed by measuring the 
release of trichloroacetic acid-soluble counts into the 
medium. Fig.1 shows the time course of glutamine 
synthetase degradation in the injected cells. The degra- 
dation is markedly accelerated by glutamine, while 
methionine sulfone, a glutamine antagonist in this 
system [8], inhibits the degradation of the enzyme 
(fig.1). The inhibition by methionine sulfone of the 
glutamine-dependent degradation (fig.1) is apparently 
due to its competition with endogenous glutamine 
[8,15]. Therefore, in subsequent experiments degra- 
dation in the presence of methionine sulfone is taken 
as a measure of the basal, glutamine-independent degra- 
dation of glutamine synthetase. It should be noted 
that the glutamine-dependent degradation of injected 
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Fig.1. Effect of glutamine and methionine sulfone on the 
degradation of ‘251glutamine synthetase. Cells were fused 
with erythrocyte ghosts loaded with ‘2SIglutamine synthe- 
tase. During fusion, 8.5% of the ghosts’ contents were trans- 
ferred to the cells resulting in 17 670 cpm/106 cells. The cells 
were suspended in growth medium without glutamine and in- 
cubated with the following additions: none (0); 5 mM glu- 
tamine (GLN) (0); 5 mM glutamine + 5 mM methionine sul- 
fone (MetSO,) (Q). 
r2’I-glutamine synthetase was only obtained with 
enzyme preparations which had been iodinated under 
mild conditions, using short iodination times (<5 s. 
section 2). 
Preincubation of cells with cycloheximide (0.4 mM) 
partially inhibits the glutamine-dependent breakdown 
of 12’1-glutamine synthetase (fig.2). On the other hand, 
cycloheximide has no effect on the basal degradation 
rate of glutamine synthetase determined in the pres- 
ence of methionine sulfone. 
Fig.3 shows the effect of the peptide protease inhib- 
itor pepstatin [ 141 on the degradation of ‘251-glutamine 
synthetase. Since pepstatin is practically impermeable 
to cells [ 161, it was necessary to inject the inhibitor 
together with the ‘251-glutamine synthetase. Under 
these conditions, pepstatin consistently inhibits the 
glutamine-dependent breakdown of glutamine syn- 
thetase. The effect of pepstatin on the basal degrada- 
tion varied fromexperiment to experiment, being very 
marked in some (fig.3) and practically zero in others 
(not shown). These results might reflect the variability 
in the amount of pepstatin which is introduced into 
the cells during the fusion procedure. Indeed, a corre- 
lation was found between the extent of inhibition of 
the basal degradation of glutamine synthetase and the 
efficiency of the microinjection. 
To test whether the factors affecting the degrada- 
tion rate of glutamine synthetase are specific for this 
protein, we have also studied the degradation of ‘*‘I- 
BSA injected into HTC cells. The average degradation 
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Fig.2. Effect of cycloheximide on the glutaminedependent 
degradation of 1251glutamine synthetase. Cells were fused 
with human erythrocyte ghosts, and 5% of the ghosts’ con- 
tents were transferred to the cells resulting in 2450 cpm/106 
cells. Cells were suspended in growth medium without glu- 
tamine, and preincubated for 30 min with (A,.) or without 
(n,o) 0.4 mM cycloheximide (CH). At zero time 5 mM glu- 
tamine (GLN) with (o,e) or without (A+) 5 mM methionine 
sulfone (MetSO,) was added as indicated, (@I) coinciding with 
(070). 
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Fig.3. The effect of pepstatin on the degradation of ra51- 
glutamine synthetase. ‘ZSIGlutamine synthetase was trap- 
ped in human erythrocyte ghosts as in section 2, in the pres- 
ence or in the absence of 1 mg pepstatin/ml. Cells were fused 
with erythrocyte ghosts loaded in the presence (a,~) or ab- 
sence (o,e) of pepstatin. Samples of each batch of cells were 
incubated either with 5 mM glutamine (GLN) (*,A) or with 
5 mM glutamine + 5 mM methionine sulfone (MetSO,) (~,a). 
rate of ‘251-BSA is faster than that of 1251-glutamine 
synthetase and is not affected by substances which 
modulate glutamine synthetase breakdown, namely 
glutamine, methionine sulfone, cycloheximide and 
pepstatin (not shown). 
To analyze the degradation products of the injected 
‘251-glutamine synthetase, extracts from injected cells 
were subjected to SDS-polyacrylamide gel electro- 
phoresis. Extracts from cells that had been incubated 
under various conditions, namely with or without 
glutamine, cycloheximide or pepstatin, revealed no 
new major radioactive bands (not shown). Thus, there 
is no evidence for the accumulation of intermediates 
of glutamine synthetase breakdown using the present 
technique. 
4. Discussion 
This investigation shows that the degradation of 
an injected protein can be subjected to regulation 
resembling that of the corresponding endogenous pro- 
tein. Degradation of injected proteins has been investi- 
gated [ 17-191 but regulation of the process by the 
injected cell had not been demonstrated. This study 
shows that the degradation of injected 1251-glutamine 
synthetase, like that of the endogenous enzyme [5,7, 
8,151, is accelerated by glutamine and this increased 
degradation is antagonized by methionine sulfone and 
inhibited by cycloheximide (fig.l,2). These observa- 
tions suggest hat the glutamine-dependent degradation 
of injected 1251-glutamine synthetase follows the same 
pathway as that of the endogenous enzyme. 
While the glutamine-dependent degradation of 
injected 1251-glutamine synthetase was consistently 
observed, the extent of degradation reached only 
lo-25% of the injected counts after a 4 h incuba- 
tion. On the other hand, the extent of degradation of 
injected r2’ I-BSA was usually -40% of the injected 
counts during a similar incubation period. A possible 
explanation of these results is suggested by our findings 
on the subcellular distribution ofthe injected proteins. 
When injected cells were fractionated as in [9], 70-90% 
of the radioactivity of ‘2SI-glutamine synthetase was 
found in the particulate fraction, whereas the injected 
12’I-BSA was almost entirely recovered in the soluble 
(cytoplasmic) fraction. Thus, the extent of 12sI-glu- 
tamine synthetase degradation might be limited by 
the amount of enzyme which is free to interact with 
the degradative system. 
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The inhibition of the degradation of ‘2SI-glutamine 
synthetase by pepstatin is particularly interesting. 
Pepstatin is a peptide protease inhibitor which strongly 
inhibits pepsin and the lysosomal protease cathepsin 
D [ 141. It is therefore likely that the lysosomal sys- 
tem is involved in the degradation of glutamine syn- 
thetase. Inhibition of protein degradation has been 
reported by pepstatin [ 16,2 1 ] and by other peptide 
inhibitors of lysosomal proteases [20,21]. Unlike glu- 
tamine synthetase, ‘*‘I-BSA injected into hepatoma 
cells is degraded through a pepstatin-insensitive path- 
way, suggesting that the 2 proteins are degraded by 
different sets of proteolytic enzymes. 
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